Studies on experimental models provided evidence that PTEN is a “haploinsufficient” tumor-suppressor gene, however, mechanisms involved in the pathogenesis of clinical manifestations in PHTS patients remain elusive. The gene discussed is PTEN; the disease is PTEN hamartoma tumor syndrome.